SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-006268
Filing Date
2017-06-06
Accepted
2017-06-06 17:32:05
Documents
64
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 656873
2 ex31-1.htm EX-31.1 17058
3 ex31-2.htm EX-31.2 16912
4 ex32-1.htm EX-32.1 8069
5 ex32-2.htm EX-32.2 7651
  Complete submission text file 0001493152-17-006268.txt   3219490

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adxs-20170430.xml EX-101.INS 474859
7 XBRL SCHEMA FILE adxs-20170430.xsd EX-101.SCH 46978
8 XBRL CALCULATION FILE adxs-20170430_cal.xml EX-101.CAL 64052
9 XBRL DEFINITION FILE adxs-20170430_def.xml EX-101.DEF 107939
10 XBRL LABEL FILE adxs-20170430_lab.xml EX-101.LAB 301190
11 XBRL PRESENTATION FILE adxs-20170430_pre.xml EX-101.PRE 216706
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 17895022
SIC: 2834 Pharmaceutical Preparations